Profile picture

Professor Hiddo Heerspink

University Medical Centre Groningen, Groningen (Netherlands (The))
Follow
Logo ESC

Contributor content

Q&A - Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.
Presentation
Q&A - Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.
Read more
Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.
Presentation
Challenging paradigms and changing the course of chronic kidney disease the era of SGLT2i.
Read more
What are the mechanisms linking novel antidiabetic treatments to cardiovascular benefit?
Presentation
What are the mechanisms linking novel antidiabetic treatments to cardiovascular benefit?
Read more
Natriuretic effect of 2 weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function: results of the DAPASALT trial
Presentation
Natriuretic effect of 2 weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function: results of the DAPASALT trial
Read more
DAPA-CKD - Dapagliflozin in Patients with Chronic Kidney Disease
Presentation
DAPA-CKD - Dapagliflozin in Patients with Chronic Kidney Disease
Read more
Hot Line DAPA-CKD.
Presentation
Hot Line DAPA-CKD.
Read more

ESC 365 is supported by

novartis Explore sponsored resources